Drug Pipeline Quarterly Update: December 2020

Drugs in review, drugs with expiring patents, generic availability and more.

December 30, 2020

These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.

December 2020 Quarterly Traditional Pipeline Update
December 2020 Quarterly Specialty Pipeline Update

Related research

Drug pipeline updates

January 13, 2022

February 2022 decisions expected from the FDA

At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…

Drug pipeline updates

December 31, 2021

Drug Pipeline Quarterly Update: December 2021

These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status…

Drug pipeline updates

December 11, 2021

January 2022 decisions expected from the FDA

Your monthly synopsis of new drugs expecting FDA decisions in January 2022 At…